A Patent Review of EZH2 Inhibitors from 2017 and BeyondGuoquan Wan,Huan Feng,Chang Su,Yongxia Zhu,Lidan Zhang,Qiangsheng Zhang,Luoting YuEXPERT OPINION ON THERAPEUTIC PATENTS（2023）引用 3|浏览14关键词Cancer,Degrader,EZH2 inhibitor,Patent,TazemetostatAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
